Profile
Doyle Janeen Noel is a person associated with Janux Therapeutics, Inc. based on SEC filings as of 2026-06-05. The exact role (e.g., officer, director, or other insider) is not explicitly stated in the provided context, and public biographical information about this individual is limited. No widely publicized achievements or professional background from major public sources are readily identifiable in connection with this name and the 2026 filing date. Further verification from Janux Therapeutics’ investor relations materials or complete SEC filings would be needed to confirm her current position, background, and career highlights.
| Role | Insider |
|---|
| Notability | 15/100 |
|---|
Board memberships
Awards & honors
- No widely publicized achievements linked to this individual in available sources as of 2026-06-05.
Frequently Asked Questions
Who is Doyle Janeen Noel?
Doyle Janeen Noel is a person associated with Janux Therapeutics, Inc. based on SEC filings as of 2026-06-05. The exact role (e.g., officer, director, or other insider) is not explicitly stated in the provided context, and public biographical information about this individual is limited. No widely publicized achievements or professional background from major public sources are …
How many SEC Form 4 filings has Doyle Janeen Noel submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Has Doyle Janeen Noel been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($57K) across all tracked filings.
Where can I see all of Doyle Janeen Noel's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.